Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04006184 · ClinicalTrials.gov registry record
Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation
A clinical trial of Venous Insufficiency and Varicose Veins, sponsored by Lake Washington Vascular.
- Completed
- Registry status
- 547
- Enrollment target
- 1
- Study location
NCT04006184: Completed study of Venous Insufficiency and Varicose Veins, sponsored by Lake Washington Vascular.
NCT04006184 is a study of Venous Insufficiency and Varicose Veins that has completed, run by Lake Washington Vascular. The registered enrollment target is 547 participants, above the 91-participant average among 9 other Venous Insufficiency trials with a reported enrollment target (501% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04006184, a study of Venous Insufficiency and Varicose Veins, has completed, sponsored by Lake Washington Vascular.
- COMPLETED
- Registry status
- 547 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenous Laser Ablation).
Primary Outcome
Compare need for/utilization of adjunctive phlebectomy performed as a concomitant or staged procedure
Conditions Studied
Interventions
- OTHER Chart review
Study Locations (1)
Washington
- Lake Washington Vascular, PLLC - Bellevue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 547 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2019-08-30 |
What the finished NCT04006184 record still lists
NCT04006184 is an observational study that tracks outcomes without assigning an intervention. The registered 547 participants enrollment target is mid-sized for trials with a published cap, above the 91-participant average among 9 other Venous Insufficiency trials with a reported enrollment target (501% higher).
The record links to 3 conditions, with Venous Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Chart review is the first listed.
NCT04006184 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04006184 about?
NCT04006184 is a clinical study titled "Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation". This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenou...
What is the current status of trial NCT04006184?
This trial is currently completed. The enrollment target is 547 participants. The study started on 2019-06-14. Estimated completion is 2019-08-30.
What conditions does trial NCT04006184 study?
This clinical trial studies the following conditions: Venous Insufficiency, Varicose Veins, Venous Reflux.
What interventions are being tested in trial NCT04006184?
The interventions under investigation include: Chart review (OTHER).
Who is sponsoring clinical trial NCT04006184?
This trial is sponsored by Lake Washington Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04006184 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04006184's enrollment target sits among peer trials
547 1st of 9 higher than 9 of 9 other Venous Insufficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Insufficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The ROle of Compression StocKings in Heart Failure Patients
RECRUITING · NA
-
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
RECRUITING · NA
-
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
ACTIVE NOT RECRUITING · NA
-
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
COMPLETED · Phase 2
-
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
COMPLETED · Phase 1
-
Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI